CIK 0001321834
- Non-accelerated filer
- Smaller reporting company
Q/C TECHNOLOGIES, INC.
Sign in to watch- Ticker
- QCLS
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 856-848-8698
- Business address
- 1185 AVENUE OF THE AMERICAS, SUITE 249, NEW YORK, NY, 10036
- Former names
- Q/C TECHNOLOGIES, INC., TNF Pharmaceuticals, Inc., MyMD Pharmaceuticals, Inc., Akers Biosciences, Inc., Akers Biosciences Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-01 | Silverman Joshua Executive Chairman | Grant or award | +77,390 | 210,845 | ||
| 2026-07-10 | Silverman Joshua Executive Chairman | Grant or award | +16,620 | 133,455 | ||
| 2026-04-13 | Silverman Joshua Executive Chairman | Grant or award | +16,806 | 116,835 | ||
| 2026-04-13 | Silverman Joshua Executive Chairman | Grant or award · Employee Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2026-04-13 | Silverman Joshua Executive Chairman | Grant or award | +162,162 | 262,191 | ||
| 2026-04-13 | Silverman Joshua Executive Chairman | Grant or award · Employee Stock Option (Right to Buy) | +100,000 | 50,000 | ||
| 2025-11-14 | Silverman Joshua Executive Chairman | Grant or award | +91,356 | 100,029 | ||
| 2025-10-03 | Silverman Joshua Executive Chairman | Grant or award | +8,644 | 8,673 | ||
| 2023-06-07 | Silverman Joshua Director | Grant or award · Employee Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2021-11-26 | Silverman Joshua Director | Purchase | +5,000 | $7.55 | $38K | 88,775 |
| 2021-11-24 | Silverman Joshua Director | Purchase | +6,734 | $6.30 | $42K | 80,509 |
| 2021-11-24 | Silverman Joshua Director | Purchase | +3,266 | $7.09 | $23K | 83,775 |
| 2021-10-14 | Silverman Joshua Director | Grant or award · Restricted Stock Units | +600,000 | 600,000 | ||
| 2021-04-16 | Silverman Joshua Director | Option exercise | +109,500 | 112,101 | ||
| 2021-04-16 | Silverman Joshua Director | Shares withheld for taxes | −38,325 | $4.94 | $189K | 71,175 |
| 2021-04-16 | Silverman Joshua Director | Option exercise · Restricted Stock Units | −109,500 | 0 | ||
| 2020-09-11 | Silverman Joshua Director | Grant or award · Restricted Stock Unit | +219,000 | 219,000 | ||
| 2020-01-01 | Silverman Joshua Director | Option exercise | +5,201 | 5,201 | ||
| 2020-01-01 | Silverman Joshua Director | Option exercise · Restricted Stock Units | +5,201 | 0 | ||
| 2019-03-29 | Silverman Joshua Director | Grant or award · Restricted Stock Units | +124,827 | 124,827 |
Page 1 of 1 · 20 trades